153 related articles for article (PubMed ID: 25659427)
1. Update on the pathophysiological implications and clinical role of angiogenic factors in pregnancy.
Llurba E; Crispi F; Verlohren S
Fetal Diagn Ther; 2015; 37(2):81-92. PubMed ID: 25659427
[TBL] [Abstract][Full Text] [Related]
2. [Angiogenic proteins: possible markers of physiopathological processes during fetal development].
Petersen TM; Larsen T; Nielsen HJ
Ugeskr Laeger; 2003 Aug; 165(32):3082-7. PubMed ID: 12951850
[TBL] [Abstract][Full Text] [Related]
3. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application.
Lapaire O; Shennan A; Stepan H
Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):122-9. PubMed ID: 20457483
[TBL] [Abstract][Full Text] [Related]
4. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.
Lam C; Lim KH; Karumanchi SA
Hypertension; 2005 Nov; 46(5):1077-85. PubMed ID: 16230516
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.
Stepan H; Unversucht A; Wessel N; Faber R
Hypertension; 2007 Apr; 49(4):818-24. PubMed ID: 17261644
[TBL] [Abstract][Full Text] [Related]
6. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
7. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between fetal growth restriction and angiogenesis factors].
Huang Y; Liu Q; Yu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1068-70. PubMed ID: 25057087
[TBL] [Abstract][Full Text] [Related]
9. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
10. Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy.
Sundrani DP; Reddy US; Chavan-Gautam PM; Mehendale SS; Chandak GR; Joshi SR
Reprod Sci; 2014 Dec; 21(12):1508-17. PubMed ID: 24803508
[TBL] [Abstract][Full Text] [Related]
11. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.
Pinheiro CC; Rayol P; Gozzani L; Reis LM; Zampieri G; Dias CB; Woronik V
Prenat Diagn; 2014 Nov; 34(11):1084-92. PubMed ID: 24916790
[TBL] [Abstract][Full Text] [Related]
12. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patrício B; Quintanilha A; Santos-Silva A
Growth Factors; 2009 Dec; 27(6):345-51. PubMed ID: 19919522
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion.
Triunfo S; Lobmaier S; Parra-Saavedra M; Crovetto F; Peguero A; Nadal A; Gratacos E; Figueras F
Placenta; 2014 Jun; 35(6):398-403. PubMed ID: 24746262
[TBL] [Abstract][Full Text] [Related]
14. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
16. Placental angiogenesis in sheep models of compromised pregnancy.
Reynolds LP; Borowicz PP; Vonnahme KA; Johnson ML; Grazul-Bilska AT; Redmer DA; Caton JS
J Physiol; 2005 May; 565(Pt 1):43-58. PubMed ID: 15760944
[TBL] [Abstract][Full Text] [Related]
17. Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.
Muller PR; James AH; Murtha AP; Yonish B; Jamison MG; Dekker G
Hypertens Pregnancy; 2006; 25(3):183-92. PubMed ID: 17065039
[TBL] [Abstract][Full Text] [Related]
18. Effect of clopidogrel on circulating biomarkers of angiogenesis and endothelial activation.
Smadja DM; Bura A; Szymezak J; Blanchard A; Remones V; Azizi M; Gaussem P
J Cardiol; 2012 Jan; 59(1):30-5. PubMed ID: 22100059
[TBL] [Abstract][Full Text] [Related]
19. Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction.
Tjoa ML; Oudejans CB; van Vugt JM; Blankenstein MA; van Wijk IJ
Hypertens Pregnancy; 2004; 23(2):171-89. PubMed ID: 15369650
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiogenic factors and their association with birth outcomes in preeclampsia.
Kulkarni AV; Mehendale SS; Yadav HR; Kilari AS; Taralekar VS; Joshi SR
Hypertens Res; 2010 Jun; 33(6):561-7. PubMed ID: 20224572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
